Category: Industry News
-
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
Responses were deep and durable, with 65% ongoing at clinical cutoff Results support continued evaluation of the investigational RYBREVANT FASPRO regimen in…
-
UK-US trade deal will mean the NHS has to divert billions from other services to pay more for new medicines
Around £45 billion in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under…
-
Cracking open a can of cannabis—America's new pastime (for now)
At Fourth of July barbecues this weekend, Americans are more likely than ever to crack open a can of cannabis rather than…
-
CHMP recommendation advances Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab as a potential standard of care for relapsed/refractory multiple myeloma
Recommendation supported by unprecedented Phase 3 data, demonstrating that TECVAYLI® in combination with daratumumab achieved statistically significant improvements in progression-free and overall…
-
Johnson & Johnson Begins Enrollment in Pivotal Studies Evaluating First-of-its-Kind Carotid IVL Platform
· U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in…
-
Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform
The Dual Energy THERMOCOOL SMARTTOUCH SF Platform combines pulsed field and radiofrequency energy delivery in a unified and integrated treatment platformi
-
How AI accelerates radiopharmaceutical drug discovery, optimizes personalized dosimetry
A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet Research. Authored by JMIR…
-
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped…
-
Research confirms safety in voluntary assisted dying
New research demonstrates that the Victorian model for oral self-administration of voluntary assisted dying (VAD) medication is safe and effective, providing the…
-
Autism research finds Phelan-McDermid syndrome may affect 1 in 7,300 people: More common than previously thought
New research, led by scientists from the Seaver Autism Center for Research and Treatment at Mount Sinai and published in Autism Research,…